NOTE AND WARRANT PURCHASE
AGREEMENT
TOMOTHERAPY
INCORPORATED,
THOMAS ROCKWELL MACKIE, PAUL J.
RECKWERDT,
THE INVESTORS NAMED
HEREIN
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Page
|
|
ARTICLE I
DEFINITIONS AND TERMS
|
|
|
1
|
|
|
|
1.1
|
|
|
|
|
|
1
|
|
|
|
1.2
|
|
|
|
|
|
9
|
|
|
|
1.3
|
|
|
|
|
|
9
|
|
|
ARTICLE II
ISSUE OF NOTES
|
|
|
10
|
|
|
|
2.1
|
|
|
|
|
|
10
|
|
|
|
2.2
|
|
|
|
|
|
11
|
|
|
|
2.3
|
|
|
|
|
|
12
|
|
|
|
2.4
|
|
|
|
|
|
13
|
|
|
ARTICLE III
CONDITIONS TO CLOSING
|
|
|
13
|
|
|
|
3.1
|
|
|
|
|
|
13
|
|
|
|
3.2
|
|
|
|
|
|
13
|
|
|
|
3.3
|
|
|
|
|
|
14
|
|
|
|
3.4
|
|
|
Proceedings and Documents
|
|
|
14
|
|
|
|
3.5
|
|
|
Organization, Good Standing and
Authority
|
|
|
14
|
|
|
|
3.6
|
|
|
Securities Law Matters; Investment
Representations
|
|
|
14
|
|
|
|
3.7
|
|
|
|
|
|
14
|
|
|
|
3.8
|
|
|
|
|
|
14
|
|
|
|
3.9
|
|
|
|
|
|
15
|
|
|
|
3.10
|
|
|
No Material Adverse Effect
|
|
|
15
|
|
|
|
3.11
|
|
|
Representations and Warranties
|
|
|
15
|
|
|
|
3.12
|
|
|
|
|
|
15
|
|
|
|
3.13
|
|
|
|
|
|
15
|
|
|
|
3.14
|
|
|
Conditions Precedent for Secondary
Loans
|
|
|
15
|
|
|
|
3.15
|
|
|
SBIC Compliance Agreement
|
|
|
16
|
|
|
ARTICLE IV
REPRESENTATIONS AND WARRANTIES
|
|
|
16
|
|
|
|
4.1
|
|
|
|
|
|
16
|
|
|
|
4.2
|
|
|
|
|
|
17
|
|
|
|
4.3
|
|
|
|
|
|
17
|
|
-i-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Page
|
|
|
4.4
|
|
|
Subsidiaries, Other Investments
|
|
|
17
|
|
|
|
4.5
|
|
|
|
|
|
18
|
|
|
|
4.6
|
|
|
|
|
|
18
|
|
|
|
4.7
|
|
|
|
|
|
18
|
|
|
|
4.8
|
|
|
|
|
|
18
|
|
|
|
4.9
|
|
|
No Undisclosed Liabilities
|
|
|
19
|
|
|
|
4.10
|
|
|
|
|
|
19
|
|
|
|
4.11
|
|
|
Compliance with Other Instruments, Laws,
Etc
|
|
|
20
|
|
|
|
4.12
|
|
|
|
|
|
20
|
|
|
|
4.13
|
|
|
|
|
|
20
|
|
|
|
4.14
|
|
|
|
|
|
20
|
|
|
|
4.15
|
|
|
|
|
|
20
|
|
|
|
4.16
|
|
|
|
|
|
20
|
|
|
|
4.17
|
|
|
Federal Reserve Regulations
|
|
|
21
|
|
|
|
4.18
|
|
|
Investment Company Act: Public Utility Holding
Company Act
|
|
|
21
|
|
|
|
4.19
|
|
|
Nondisclosure, Noncompetition and Inventions
Agreements; Employees
|
|
|
21
|
|
|
|
4.20
|
|
|
|
|
|
21
|
|
|
|
4.21
|
|
|
Amendments to the Articles of Incorporation and
Bylaws
|
|
|
22
|
|
|
|
4.22
|
|
|
|
|
|
22
|
|
|
|
4.23
|
|
|
Survival of Representations and
Warranties
|
|
|
22
|
|
|
ARTICLE V
AFFIRMATIVE COVENANTS
|
|
|
22
|
|
|
|
5.1
|
|
|
|
|
|
23
|
|
|
|
5.2
|
|
|
Maintain Corporate Existence and
Rights
|
|
|
23
|
|
|
|
5.3
|
|
|
|
|
|
23
|
|
|
|
5.4
|
|
|
|
|
|
23
|
|
|
|
5.5
|
|
|
|
|
|
24
|
|
|
|
5.6
|
|
|
|
|
|
25
|
|
|
|
5.7
|
|
|
|
|
|
25
|
|
|
|
5.8
|
|
|
|
|
|
26
|
|
-ii-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Page
|
|
|
5.9
|
|
|
|
|
|
26
|
|
|
|
5.10
|
|
|
Notice to Shareholders; Attendance at
Meetings
|
|
|
26
|
|
|
|
5.11
|
|
|
Compliance with Instruments, Laws,
Etc
|
|
|
26
|
|
|
|
5.12
|
|
|
Payment of Certain Expenses
|
|
|
26
|
|
|
|
5.13
|
|
|
Section 1202 Capital Gains
Treatment
|
|
|
26
|
|
|
|
5.14
|
|
|
|
|
|
26
|
|
|
|
5.15
|
|
|
Right to Purchase Additional Shares
|
|
|
27
|
|
|
|
5.16
|
|
|
|
|
|
27
|
|
|
|
5.17
|
|
|
|
|
|
27
|
|
|
|
5.18
|
|
|
Amendment of Articles of Incorporation and
Bylaws
|
|
|
28
|
|
|
ARTICLE VI
NEGATIVE COVENANTS
|
|
|
28
|
|
|
|
6.1
|
|
|
|
|
|
28
|
|
|
|
6.2
|
|
|
Investments, Loans and Advances
|
|
|
28
|
|
|
|
6.3
|
|
|
Acquisition or Sale of Business; Merger or
Consolidation
|
|
|
29
|
|
|
|
6.4
|
|
|
|
|
|
29
|
|
|
|
6.5
|
|
|
Shareholder-Employees’ Salaries
|
|
|
29
|
|
|
|
6.6
|
|
|
Amend, Violate Charter, Etc
|
|
|
30
|
|
|
|
6.7
|
|
|
Compliance With Securities Laws
|
|
|
30
|
|
|
|
6.8
|
|
|
|
|
|
30
|
|
|
|
6.9
|
|
|
|
|
|
30
|
|
|
|
6.10
|
|
|
Pension and Profit-Sharing Plan or
Arrangements
|
|
|
30
|
|
|
|
6.11
|
|
|
|
|
|
30
|
|
|
|
6.12
|
|
|
|
|
|
30
|
|
|
|
6.13
|
|
|
|
|
|
31
|
|
|
|
6.14
|
|
|
|
|
|
31
|
|
|
|
6.15
|
|
|
|
|
|
31
|
|
|
ARTICLE VII
EVENTS OF DEFAULT AND REMEDIES THEREFOR
|
|
|
31
|
|
|
|
7.1
|
|
|
|
|
|
31
|
|
|
|
7.2
|
|
|
|
|
|
33
|
|
-iii-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Page
|
|
|
7.3
|
|
|
|
|
|
33
|
|
|
|
7.4
|
|
|
|
|
|
33
|
|
|
|
7.5
|
|
|
|
|
|
33
|
|
|
ARTICLE VIII
TRANSFERABILITY
|
|
|
34
|
|
|
|
8.1
|
|
|
|
|
|
34
|
|
|
|
8.2
|
|
|
Representations and Warranties of the
Investors
|
|
|
34
|
|
|
|
8.3
|
|
|
|
|
|
35
|
|
|
|
8.4
|
|
|
|
|
|
35
|
|
|
ARTICLE IX
REGISTRATION RIGHTS
|
|
|
36
|
|
|
|
9.1
|
|
|
|
|
|
36
|
|
|
|
9.2
|
|
|
|
|
|
36
|
|
|
|
9.3
|
|
|
|
|
|
37
|
|
|
|
9.4
|
|
|
Indemnification of the Rightholders
|
|
|
40
|
|
|
|
9.5
|
|
|
Indemnification of the Company
|
|
|
42
|
|
|
|
9.6
|
|
|
|
|
|
42
|
|
|
|
9.7
|
|
|
|
|
|
42
|
|
|
|
9.8
|
|
|
No Further Grants of Registration
Rights
|
|
|
43
|
|
|
ARTICLE X
PUT OPTION; CO-SALE RIGHTS
|
|
|
43
|
|
|
|
10.1
|
|
|
|
|
|
43
|
|
|
|
10.2
|
|
|
|
|
|
43
|
|
|
|
10.3
|
|
|
|
|
|
44
|
|
|
|
10.4
|
|
|
Adjustment of Purchase Price
|
|
|
44
|
|
|
|
10.5
|
|
|
|
|
|
44
|
|
|
ARTICLE XI
INDEMNIFICATION
|
|
|
45
|
|
|
|
11.1
|
|
|
|
|
|
45
|
|
|
|
11.2
|
|
|
|
|
|
46
|
|
|
ARTICLE XII
ADDITIONAL PROVISIONS
|
|
|
46
|
|
|
|
12.1
|
|
|
|
|
|
46
|
|
|
|
12.2
|
|
|
|
|
|
46
|
|
-iv-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Page
|
|
|
12.3
|
|
|
|
|
|
46
|
|
|
|
12.4
|
|
|
No Waiver; Remedies Cumulative
|
|
|
47
|
|
|
|
12.5
|
|
|
|
|
|
47
|
|
|
|
12.6
|
|
|
|
|
|
47
|
|
|
|
12.7
|
|
|
|
|
|
47
|
|
|
|
12.8
|
|
|
|
|
|
47
|
|
|
|
12.9
|
|
|
|
|
|
48
|
|
|
|
12.10
|
|
|
|
|
|
48
|
|
|
|
12.11
|
|
|
|
|
|
48
|
|
|
|
|
|
|
|
|
Form of
Borrowing Request
|
|
|
|
Form of
Collateral Assignment
|
|
|
|
Form of
Security Agreement
|
|
|
|
Form of
Note
|
|
|
|
Form of
Warrant
|
|
|
|
Form of Opinion
of Counsel
|
|
|
|
|
|
|
|
Permitted
Transferees
|
|
|
|
Loan
Commitments
|
|
|
|
Liens
|
|
|
|
Capital
Stock
|
|
|
|
Outstanding
Subscriptions, Options, Warrants and Other Rights, Restrictions and
Agreements
|
|
|
|
Financial
Statements
|
|
|
|
Intellectual
Property
|
|
|
|
Undisclosed
Liabilities
|
|
|
|
Contracts
|
|
|
|
Use of
Proceeds
|
-v-
NOTE AND WARRANT PURCHASE
AGREEMENT
This NOTE AND
WARRANT PURCHASE AGREEMENT, dated as of May 1, 2003, is by and
among the Investors listed in Appendix I (the “
Investors ”), TomoTherapy Incorporated, a Wisconsin
corporation (the “ Company ”), Dr. Thomas
Rockwell Mackie (“ Mackie ”) and Paul J.
Reckwerdt (“ Reckwerdt ”; and together with
Mackie, the “ Principals ”).
WHEREAS, the
Investors desire to make an investment in the Company, and the
Company desires such investment, upon the terms and subject to the
conditions set forth herein, in the aggregate amount of up to the
amount specified in Schedule 2.1, which may be
augmented from time to time to time upon the consent of the
Required Investors with the addition of new Investors, but such
amount shall not exceed $4,000,000.
NOW, THEREFORE, in
consideration of the mutual representations, warranties and
covenants contained herein, and other good and valuable
consideration, the receipt and sufficiency of which are hereby
acknowledged, the parties hereto agree as follows:
1.1
Definitions . As used in this Agreement, the following terms
have the following meanings:
“
Advantage ” shall mean Advantage Capital Wisconsin
Partners I, Limited Partnership, a Wisconsin limited
partnership.
“
Affiliate ” of a Person shall mean any Person directly
or indirectly controlling or controlled by, or under direct or
indirect common control with, another Person. A Person shall be
deemed to control another Person for the purposes of this
definition if the controlling Person directly or indirectly, either
individually or together with (in the case of an individual) his or
her spouse, lineal descendants and ascendants and brothers or
sisters by blood or adoption or spouses of such descendants,
ascendants, brothers and sisters, owns ten percent or more of any
class of voting securities of the controlled Person or possesses,
directly or indirectly, the power to direct, or cause the direction
of, the management or policies of the second Person, whether
through the ownership of voting securities, common directors,
trustees or officers, by contract or otherwise.
“
Agreement ” shall mean this Note and Warrant Purchase
Agreement, as amended, restated, supplemented or otherwise modified
from time to time.
“
Automatic Conversion ” shall have the meaning assigned
in Section 2.2(a) .
“
Avalon ” shall mean Avalon Technology, LLC, a Michigan
limited liability company.
“
Borrowing Request ” shall mean the borrowing request
for Loans, substantially in the form of Exhibit A
hereto.
“
Business Day ” shall mean a day other than a Saturday
or Sunday on which banks are open for business in Madison,
Wisconsin.
“ Capital
Stock ” shall have the meaning assigned in
Section 4.3(a) .
“
Capitalized Lease Obligations ” shall mean, for any
period, the aggregate discounted present value of the obligations
of the Company as lessee under any lease of Property which would
properly be classified as a capitalized lease in the Financial
Statements of the Company.
“
CAPCO ” shall mean a “certified capital
company” as that term is defined under Section 560.30(2) of
the Wisconsin Statutes, as may be amended from time to time
(including a successor statute thereto).
“
Cause ” shall have the meaning assigned in
Section 7.1(i) .
“
Claim ” shall have the meaning assigned in
Section 11.1 .
“ Closing
Date ” shall have the meaning assigned in
Section 2.4 .
“
Code ” shall mean the Internal Revenue Code of 1986,
as amended from time to time.
“
Collateral ” shall mean all of Company’s
Property granted to the Investors as collateral under the Loan
Documents.
“
Collateral Assignment ” shall mean the collateral
assignment of contract rights of even date herewith, from the
Company to the Investors, substantially in the form of Exhibit
B hereto, pursuant to which the Company assigns its rights
under the WARF License Agreement, as amended, supplemented or
modified from time to time.
“ Common
Shares ” shall mean shares of the Company’s common
stock, par value $0.01 per share.
“
Company ” shall have the meaning assigned in the first
paragraph to this Agreement.
“ Consent
to Conversion ” shall have the meaning assigned in
Section 2.2(a) .
“
Conversion Price ” shall have the meaning assigned in
Section 2.2(a) .
-2-
“
Default ” shall mean an event which with the giving of
notice or the passage of time or both would constitute an Event of
Default.
“ Demand
Registration ” shall have the meaning assigned in
Section 9.1(a) .
“
Employee Plan ” shall mean any savings, profit
sharing, or retirement plan or any deferred compensation contract
or other plan maintained for employees of the Company and covered
by Title IV of ERISA, including, without limitation, any
“multiemployer plan” as defined in ERISA.
“ The
Endeavors Group ” shall mean The Endeavors Group, LLC, a
Wisconsin limited liability company.
“
Environmental Law ” shall mean any local, state or
federal law or other statute, law, ordinance, rule, code,
regulation, decree or order governing, regulating or imposing
liability or standards of conduct concerning the use, treatment,
generation, storage, disposal or other handling or release of any
hazardous substance, including without limitation, any pollutant,
contaminant, waste or toxic or hazardous chemicals, wastes or
substances, including, without limitation, asbestos, urea
formaldehyde insulation, petroleum, PCB’s, air pollutants,
water pollutants, and other substances defined as hazardous
substances or toxic substances in the Comprehensive Environmental
Response, Compensation and Liability Act of 1980, as amended, 42
U.S.C. § 9061 et seq., Hazardous Materials Transportation Act,
49 U.S.C. Section 1802, the Resource Conservation and Recovery
Act, 42 U.S.C. § 6901 et seq., the Toxic Substance Control Act
of 1976, as amended, 15 U.S.C. § 2601 et seq., the Solid Waste
Disposal Act, 42 U.S.C. § 3251 et seq., the Clean Air Act, 42
U.S.C. § 1857 et seq., the Clean Water Act, 33 U.S.C. §
1251 et seq, Chapter 144 of the Wisconsin Statutes, or any
other statute, rule, regulation or order of any Governmental
Authority having jurisdiction over the control of such wastes or
substances, including without limitation the United States
Environmental Protection Agency, the United States Nuclear
Regulatory Agency, the State of Wisconsin and the Dane County
Department of Health.
“
ERISA ” shall mean the Employee Retirement Income
Security Act of 1974, as amended, and any successor statute,
together with the regulations and published interpretations
thereunder, in each case as in effect from time to time.
“ Event
of Default ” shall have the meaning assigned in
Section 7.1 .
“
Exercise Price ” shall mean the Automatic Conversion
Price if Series D Preferred Shares are issuable upon exercise
of a Warrant, or the Optional Conversion Price if Series C
Preferred Shares are issuable upon exercise of a Warrant, each
price as may be adjusted from time to time pursuant to
Section 3 of the Warrant.
“ Fair
Market Value ” shall have the meaning assigned in
Section 10.2(d) .
“
Financial Statements ” shall mean, for any Person, the
balance sheet, the statement of income, the statement of cash
flows, and the statement of shareholders’ equity, and all
notes and schedules thereto, prepared on a consolidated basis, in
accordance with GAAP.
-3-
“
GAAP ” shall mean those generally accepted accounting
principles in the United States of America consistently applied for
all periods so as to properly reflect the financial condition,
results of operations, and cash flows of the Company.
“
Governmental Authority ” shall mean any nation or
government, any state or other political subdivision thereof, and
any entity exercising executive, legislative, judicial, regulatory
or administrative functions of or pertaining to government, and any
corporation or other entity owned or controlled through stock or
capital ownership or otherwise, by any of the foregoing.
“
Indebtedness ” shall mean all: (a) indebtedness
for borrowed money; (b) indebtedness for the deferred purchase
price of property or services for which the Company is liable,
primarily, contingently or otherwise, as obligor, guarantor or
otherwise; (c) any commitment by which the Company assures a
creditor against loss, including, without limitation, contingent
reimbursement obligations with respect to letters of credit;
(d) obligations which are evidenced by notes, acceptances or
other instruments; (e) indebtedness and other obligations
arising under acceptance facilities and the face amount of all
letters of credit issued for the account of the Company; (f)
indebtedness guarantied in any manner by the Company, including
without limitation guaranties in the form of an agreement to
repurchase or reimburse; (g) Capitalized Lease Obligations,
for which obligations the Company is liable, primarily,
contingently or otherwise, as obligor, guarantor or otherwise, or
in respect of which obligations the Company assures a creditor
against loss; (h) any unfunded obligation of the Company to an
Employee Plan; (i) all Liabilities secured by any Lien on any
Property owned by the Company whether or not the Company has
assumed or otherwise become liable for the payment thereof; and
(j) indebtedness or other obligations arising under
interest-rate swap agreements and other interest-rate hedging
arrangements.
“
Indemnitees ” shall have the meaning assigned in
Section 11.1 .
“ Initial
Closing Date ” shall have the meaning assigned in
Section 2.4 .
“ Initial
Loan ” and “ Initial Loans ” shall
have the meaning assigned in Section 2.1(a)
.
“ Initial
Note ” and “ Initial Notes ” shall
have the meaning assigned in Section 2.1(a).
“
Intellectual Property ” shall have the meaning
assigned in Section 4.8 .
“
Investors ” shall have the meaning assigned in the
first paragraph to this Agreement. Appendix I may be
augmented from time to time upon the consent of the Required
Investors.
“
Knowledge ” when referring to the Company, shall mean
the actual knowledge of any of the following persons: any of the
Principals, Chief Executive Officer, President, Chief Financial
Officer, Director of Research, Director of Product Development,
Director of Regulatory Affairs, and Scientific Director.
“ Lead
Investor ” shall mean VI.
-4-
“
Liability ” means any liability or obligation (whether
known or unknown, whether asserted or unasserted, whether absolute
or contingent, whether accrued or unaccrued, whether liquidated or
unliquidated, and whether due or to be come due), including,
without limitation, any guaranties of Indebtedness, liabilities or
other obligations.
“
Liens ” shall mean any mortgage, pledge, lien,
encumbrance, charge or other security interest of any
kind.
“
Loan ” and “ Loans ” shall have the
meaning assigned in Section 2.1(b) .
“ Loan
Documents ” shall mean this Agreement, the Notes, the
Security Agreement, the Collateral Assignment, the Warrants, and
the UCC Financing Statements.
“
Mackie ” shall have the meaning assigned in the first
paragraph to this Agreement.
“
Material Adverse Effect ” shall mean (a) a
Default, (b) a material adverse change in the business,
prospects or condition (financial or otherwise) of the Company or
in any Property, (c) the termination of the WARF License
Agreement, (d) any material impairment of the right to carry
on the business as now or proposed to be conducted by the Company,
or (e) any material impairment of the ability of the Company
to perform its obligations under this Agreement or the transactions
contemplated hereby.
“
Maturity Date ” shall have the meaning assigned in
Section 2.1(c) .
“ Minimum
Investors ” shall mean those Investors who, individually
or with their Affiliates, have committed to invest at least
$250,000 of the outstanding principal amount of all Loans, or if
the Loans have been converted, shall mean the Investor or Investors
holding at least $250,000 of the equivalent number of Underlying
Shares.
“
NASD ” shall have the meaning assigned in
Section 9.3(a) .
“
Nondisclosure, Noncompetition and Inventions Agreement
” shall mean the Nondisclosure, Noncompetition and Inventions
Agreement between the Company and each of the Principals, and each
of the Company’s other employees.
“
Note ” and “ Notes ” shall have the
meaning assigned in Section 2.1(b) .
“ Open
Prairie Ventures ” shall mean Open Prairie Ventures I,
L.P., an Illinois limited partnership.
“
Optional Conversion ” shall have the meaning assigned
in Section 2.2(b) .
“
PBGC ” shall mean the Pension Benefit Guaranty
Corporation established pursuant to Subtitle A of Title IV of
ERISA.
-5-
“
Permitted Liens ” shall mean: (a) Liens imposed
by law and incurred in the ordinary course of the Company’s
business for Indebtedness not yet due to carriers, warehousemen,
laborers, or materialmen and the like; (b) Liens in respect of
pledges or deposits under worker’s compensation laws or
similar legislation; (c) Liens for property taxes, assessments
or governmental charges not yet subject to penalties for
nonpayment; (d) Liens created in connection with Indebtedness
incurred in compliance with Section 6.11(b) ;
(e) Liens granted to the Investors pursuant to the Loan
Documents; and (f) Liens disclosed on Schedule 3.9
.
“
Permitted Transferee ” shall have the meaning assigned
in Schedule 1.1 .
“
Person ” shall mean an individual, partnership,
corporation, limited liability company, firm, enterprise, business
trust, joint stock company, trust, unincorporated association,
joint venture, Governmental Authority or other entity of whatever
nature.
“
Preferred Shares ” shall mean, collectively, the
Series A Preferred Shares, the Series B Preferred Shares, the
Series C Preferred Shares, and the Series D Preferred
Shares.
“
Principals ” shall have the meaning assigned in the
first paragraph to this Agreement.
“
Property ” shall mean any interest of the Company of
any kind in property or assets, whether real, personal, mixed,
tangible or intangible, wherever located, and whether now owned or
subsequently acquired or arising and in the products, proceeds,
additions and accessions thereof or thereto.
“
Purchase Amount ” shall have the meaning assigned in
Section 10.2(a) .
“ Put
” shall have the meaning assigned in Section 10.1
.
“ Put
Shares ” shall have the meaning assigned in
Section 10.1 .
“
Qualified Public Offering ” shall mean an offering of
equity securities of the Company pursuant to an effective
registration statement filed with the SEC under the Securities Act
by an underwriter selected in accordance with
Section 9.1 and pursuant to a firm underwriting
agreement which raises gross proceeds to the Company of not less
than $20,000,000 and where the price per share is not less than
$26.5704, subject to adjustments for subdivisions, stock splits,
combinations, recapitalizations or similar transactions.
“
Qualified Series D Financing ” shall have the
meaning assigned in Section 2.2(a) .
“
Reckwerdt ” shall have the meaning assigned in the
first paragraph to this Agreement.
“
Repayment Notice ” shall mean a written notice by the
Company to all the Investors then holding Notes of the
Company’s intent to repay the Notes, which notice provides
(i) that the Company desires to repay the outstanding
principal amount of all the outstanding Notes, plus all
-6-
accrued but
unpaid interest on such principal amounts, (ii) that the
Company has adequate funds to repay such amounts (or access to
immediately available and adequate funds to repay such amounts),
(iii) the proposed time, date and place of repayment, which
date shall be no earlier than the Maturity Date and shall not be
less than thirty (30) days following such written notice being
given to all the Investors then holding Notes, and (iv) that
the principal and interest due under the Notes may be converted at
any time prior to the proposed repayment date in accordance with
the terms and conditions of the Notes and this
Agreement.
“
Required Investors ” shall mean the Investor or
Investors holding at least seventy-five percent (75%) of the
outstanding principal amount of all Loans, or if the Loans have
been converted, shall mean the Investor or Investors holding at
least seventy-five percent (75%) of the Underlying Shares (assuming
conversion of all of the Loans into Underlying Shares) held by all
of the Investors from time to time.
“
Restricted Payments ” shall mean: (a) dividends
or other distributions by the Company based upon the stock of the
Company (except dividends payable solely in stock of the Company);
(b) purchases, redemptions or other acquisitions, direct or
indirect, by the Company, of stock of the Company, whether now or
hereafter outstanding; (c) any other distribution by the
Company in respect of stock of the Company, whether now or
hereafter outstanding, either directly or indirectly, whether in
cash or property or otherwise; and (d) payment of management
or other fees by the Company to any Affiliate, either directly or
indirectly, whether in cash or property or otherwise, unless the
payment of such fees are approved by the Required
Investors.
“
Rightholders ” shall have the meaning assigned in
Section 9.1(a) .
“ SEC
” shall have the meaning assigned in
Section 8.2(a) .
“
Secondary Loan ” and “ Secondary Loans
” shall have the meaning assigned in
Section 2.1(b) .
“
Secondary Note ” and “ Secondary Notes
” shall have the meaning assigned in
Section 2.1(b) .
“
Securities Act ” shall mean the Securities Act of
1933, as amended, and any successor statute, together with the
rules and regulations thereunder, in each case as in effect from
time to time.
“
Securities Exchange Act ” shall mean the Securities
Exchange Act of 1934, as amended, and any successor statute,
together with the rules and regulations thereunder, in each case as
in effect from time to time.
“
Security Agreement ” shall mean the general business
security agreement of even date herewith, between the Company and
the Investors, substantially in the form of Exhibit C
hereto, pursuant to which the Company grants a Lien to the
Investors in substantially all of the Company’s Property, as
amended, restated, supplemented or otherwise modified from time to
time.
-7-
“
Series A Investment Agreement ” shall mean the
Investment Agreement dated as of May 19, 1999, by and among Venture
Investors Early Stage Fund II Limited Partnership, Avalon, the
Company and the Principals as amended on the date hereof and as it
may be further amended, restated, supplemented or otherwise
modified from time to time.
“
Series A Preferred Shares ” shall mean shares of
the Company’s Series A Preferred Stock, par value $1.00
per share.
“
Series B Investment Agreement ” shall mean the
Investment Agreement dated as of March 16, 2001, by and among the
Company, the Principals, and the investors named therein, as
amended on the date hereof and as it may be further amended,
restated, supplemented or otherwise modified from time to
time.
“
Series B Preferred Shares ” shall mean shares of
the Company’s Series B Preferred Stock, par value $1.00
per share.
“
Series C Conversation Price ” shall have the
meaning assigned in Section 2.2(a) .
“
Series C Investment Agreement ” shall mean the
Investment Agreement, dated as of August 28, 2002, by and
among the Company, the Principals, and the investors named therein,
as amended on the date hereof and as it may be further amended,
restated, supplemented or otherwise modified from time to
time.
“
Series C Preferred Shares ” shall mean shares of
the Company’s Series C Preferred Stock, par value $1.00
per share.
“
Series D Conversation Price ” shall have the
meaning assigned in Section 2.2(a) .
“
Series D Preferred Shares ” shall have the
meaning assigned in Section 2.2(a) .
“
Shareholders Agreement ” shall mean the Shareholders
Agreement, dated as of March 16, 2001, among the Company, the
Principals, the investors under the Series A Investment
Agreement, the investors under the Series B Investment
Agreement, and the investors under the Series C Investment
Agreement, as the same may be amended, restated, supplemented or
otherwise modified from time to time.
“ Subject
Shares ” shall have the meaning assigned in
Section 9.3(a) .
“
Subsidiary ” shall mean, as to any Person, a
corporation or other Person of which equity interests having voting
power (other than equity interests having such power only by reason
of the happening of a contingency that has not occurred) sufficient
to elect a majority of the board of directors or other managers of
such corporation or other Person are at the time owned, or the
management of which is otherwise controlled, directly, or
indirectly through one or more intermediaries, or both, by such
Person.
-8-
“ UCC
Financing Statements ” shall mean that certain UCC-1
financing statement and that certain UCC-3 financing statement with
the Company, as debtor, and the Investors, as secured party,
describing the Collateral.
“
Underlying Shares ” shall mean the Preferred Shares
issuable upon conversion of the Notes and exercise of the Warrants
and the Common Shares issuable upon conversion of the Preferred
Shares.
“ VI
” shall mean Venture Investors Early Stage Fund III Limited
Partnership, a Wisconsin limited partnership.
“ WARF
License Agreement ” shall mean that certain License
Agreement dated as of February 22, 1999 between the Company
and the Wisconsin Alumni Research Foundation, as the same may be
amended, restated, supplemented or otherwise modified from time to
time.
“
Warrants ” shall have the meaning assigned in
Section 2.3 .
1.2
Interpretation . Unless otherwise expressly provided or
unless the context requires otherwise, (a) all references in
this Agreement to Articles, Sections, Schedules and Exhibits shall
mean and refer to Articles, Sections, Schedules and Exhibits of
this Agreement; (b) all references to statutes and related
regulations shall include all amendments of the same and any
successor or replacement statutes and regulations; (c) words
using the singular or plural number also shall include the plural
and singular number, respectively; (d) references to
“hereof,” “herein,” “hereby”
and similar terms shall refer to this entire Agreement (including
the Schedules and Exhibits hereto); and (e) references to any
Person shall be deemed to mean and include the successors and
permitted assigns of such Person (or, in the case of a Governmental
Authority, Persons succeeding to the relevant functions of such
Person).
1.3 Other
Terms . Except as otherwise specifically provided, each
accounting term used herein shall have the meaning given to it
under GAAP.
(a) The
Investors severally (but not jointly) agree, subject to the terms
and conditions set forth herein, to make a loan to the Company on
the Initial Closing Date, in the aggregate amount of fifty percent
(50%) of the aggregate loan commitments specified in
Schedule 2.1 (as of the date of making such loan), each
loaning an amount equal to its pro rata share of the
aggregate loan commitments as set forth in Schedule 2.1
(collectively the “ Initial Loans ”, and each is
an “ Initial Loan ”). The obligations of the
Company to repay the Initial Loans shall be evidenced
-9-
by the
Company’s 12% Convertible Notes in the form attached hereto
as Exhibit D , the terms for such form may be modified
for Loans from CAPCOs in order to comply with relevant statutes and
regulations (collectively the “ Initial Notes ”,
and each is an “ Initial Note ”).
(b) Upon
not less than twenty (20) days’ prior written notice to
the Investors by the Company’s submission of a Borrowing
Request, the Investors severally (but not jointly) agree, subject
to the terms and conditions set forth herein, to make in the
aggregate up to two additional Loans to the Company on the
borrowing date set forth in the Company’s notice (but not
earlier than the twentieth (20 th )
day following the date such written notice is given), each such
Loan in an amount equal to their pro rata share of twenty
five percent (25%) of the aggregate loan commitments specified in
Schedule 2.1 (as of the date of making such loan)
(collectively the “ Secondary Loans ”, and each
is a “ Secondary Loan ”; the Secondary Loans and
the Initial Loans are collectively referred to as the “
Loans ”, and each as a “ Loan ”);
provided, if Schedule 2.1 is augmented by the addition
of new Investors as contemplated in the Recitals to this Agreement,
an equitable adjustment will be made by the Required Investors (i)
to require that such new Investor contribute the same percentage of
such new Investor’s total commitment as that contributed
cumulatively by the other Investors as of such date ( e.g. ,
if a new Investor comes in after the Initial Loan but prior to the
first Secondary Loan, such new Investor will contribute 75% of such
new Investor’s total commitment as part of the first
Secondary Loan, which percentage is equal to the cumulative total
percentage of the amounts contributed by the other Investors as of
the date the first Secondary Loan is made), and (ii) to adjust
the aggregate amount available to be loaned to the Company to
reflect the new Investor’s commitment. In no event shall any
Secondary Loan be made after March 1, 2004. The obligations of
the Company to repay the Secondary Loans shall be evidenced by the
Company’s 12% Convertible Senior Subordinated Notes in the
form attached hereto as Exhibit D , the terms for such
form may be modified for Loans from CAPCOs in order to comply with
relevant statutes and regulations (collectively the “
Secondary Notes ”, and each is a “ Secondary
Note ”; the Secondary Notes and the Initial Notes are
collectively referred to as the “ Notes ”, and
each as a “ Note ”).
(c) If
any Investor required to fund any given Secondary Loan fails to
fund such Secondary Loan in accordance with
Section 2.1(b) , then such Investor shall not be issued
any Warrants with respect to any Loans previously made by such
Investor.
(d) No
amount of the Loans that is repaid by the Company may be reborrowed
hereunder. Permitted repayments of the Loans shall be made pro
rata among the Investors. Unless converted pursuant to
Section 2.2 or maturity is accelerated following an
Event of Default, the outstanding principal balance and all accrued
and unpaid interest under the Notes shall be payable in full in
immediately available funds no earlier than April 30, 2004
(the “ Maturity Date ”). The Company shall pay
the outstanding principal amounts under the Notes, plus all accrued
but unpaid interest on such principal amounts, upon the earlier of
(i) the date specified by the Company that is on or after the
Maturity Date and which date is no earlier than thirty (30) days
following the Company’s delivery of a Repayment Notice to all
the Investors then holding Notes, but subject to any earlier
conversion of the Notes prior to the end of such thirty-day period,
or (ii) within three business days of a request to do so
submitted by the Required Investors (excluding therefrom, the vote
or holdings of the CAPCOs), which repayment date shall be no
earlier than the Maturity Date.
-10-
In order to
submit a Repayment Notice to the Investors, the Company shall have
adequate funds (or access to immediately available and adequate
funds) to repay all the Notes in full at the time the Repayment
Notice is delivered to the Investors and at the time and date
proposed for repayment. Interest on the Notes shall accrue and
compound daily at the rate of twelve percent (12.00%) per annum,
with interest calculated based upon a year consisting of
365 days for actual days elapsed; provided ,
however , that at all times following the occurrence
and during the continuation of an Event of Default, interest shall
accrue thereafter at the rate of eighteen percent (18%) per annum.
Notwithstanding anything to the contrary contained in this
Section 2.1(d) , the terms for any Notes issued to a
CAPCO may vary from the provisions set forth herein in order to
comply with applicable state statutes and regulations; if the terms
of a Note issued to a CAPCO conflict with the terms contained
herein, the terms of the Note issued to the CAPCO shall
control.
(a) Upon
(i) the Company’s receipt of not less than $5,000,000 in
gross proceeds from the sale of its Series D Convertible
Preferred Stock (“ Series D Preferred Shares
”) from an institutional investor or investors other than the
Investors on or before the Maturity Date (a “ Qualified
Series D Financing ”), or (ii) the written
consent of the Required Investors to automatically convert all the
Notes (“ Consent to Conversion ”) at or after
the Maturity Date (unless the Company has submitted to the
Investors holding Notes a Repayment Notice, in which case such
Consent to Conversion may be submitted at any time following the
submission of the Repayment Notice but prior to the actual
repayment date), then the outstanding principal balance and all
accrued and unpaid interest in respect of all of the Notes shall
automatically be converted to Series D Preferred Shares (an
“ Automatic Conversion ”); provided
however, if upon a Consent to Conversion there is not any
Series D Preferred Shares authorized, then the outstanding
principal balance and all accrued and unpaid interest in respect of
the Notes shall automatically be converted to Series C
Preferred Shares; provided further , if upon a
Consent to Conversion there are any Series D Preferred Shares
authorized, the Required Investors shall decide in such written
consent whether to convert the outstanding principal balance and
all accrued and unpaid interest in respect of the Notes into either
Series D Preferred Shares or Series C Preferred Shares.
If the Notes are to be converted into Series D Preferred
Shares, the conversion price shall be equal to the lowest price per
share paid in the Qualified Series D Financing or if there has
been no Qualified Series D Financing, the lowest price paid
for any Series D Preferred Shares (the “
Series D Conversion Price ”). If the Notes are to
be converted into Series C Preferred Shares, the conversion
price shall equal $8.178 per share (subject to the adjustments
specified in the Notes) (the “ Series C Conversion
Price ”; the Series C Conversion Price and the
Series D Conversion Price are collectively referred to as the
“ Conversion Price ”). Upon the request of the
Company following an Automatic Conversion, the Investors shall
deliver the Notes to the Company for cancellation, and the Company
shall issue and deliver stock certificates representing the
Series D Preferred Shares or Series C Preferred Shares,
as the case may be, in such converted amount to each Investor. The
Company and the Investors shall execute and deliver cross-receipts
acknowledging such Automatic Conversion. Upon a Qualified
Series D Financing, each Investor shall be entitled to (but
shall not be obligated to) execute counterparts of, and become a
party to, the investment agreement and related agreements to be
entered into in connection with the Qualified Series D
Financing; provided , that upon their execution of such
investment agreement and related agreements in
connection
-11-
with the
Qualified Series D Financing or if an Investor refuses to
execute such investment agreement and related agreements, the
Series D Preferred Shares held by such Investor shall cease to
be covered by this Agreement.
(b) In
the event that an Automatic Conversion has not occurred, after the
Maturity Date, each of the Investors, at the option of each
Investor, shall (x) have a continuing option (but not the
obligation), exercisable at any time or from time to time, to
convert all or any portion of the outstanding principal amount and
accrued and unpaid interest under the Notes into the
Company’s Series C Preferred Shares (an “
Optional Conversion ”) at a conversion price equal to
the Series C Conversion Price, and (y) continue to have
their respective rights and remedies under the Notes, at law and in
equity, subject to the limitations of this Agreement and the other
Loan Documents. Upon an Optional Conversion, (i) each of the
Investors requesting an Optional Conversion shall deliver Note(s)
to the Company for cancellation, (ii) the Company shall issue
and deliver stock certificate(s) representing the Series C
Preferred Shares in such converted amount to each of the Investors
requesting an Optional Conversion, and (iii) if the Optional
Conversion is in less than the full amount of outstanding principal
and accrued and unpaid interest under any Note, the Company shall
reissue such Note to each of the Investors requesting an Optional
Conversion in an amount equal to the then outstanding balance less
the converted portion thereof. The Company and each of the
Investors who request an Optional Conversion shall execute and
deliver cross-receipts acknowledging any Optional
Conversion.
2.3
Warrants . As an inducement for the Investors to convert the
Loans, but subject to the provisions of Section 2.1(c)
, the Company shall issue and deliver to each Investor upon the
conversion of the Note or Notes held by such Investor, a warrant to
purchase the number of Series D Preferred Shares or
Series C Preferred Shares, as the case may be, that is equal
to the quotient of the product of the principal amount of the Loans
made by the Investor times .2 divided by the Exercise
Price at the time of issuance. Such warrants (the “
Warrants ”) shall be in the form of
Exhibit E . Upon such issuance and delivery, the
Company shall have a sufficient number of authorized Underlying
Shares to effectuate the exercise of each Warrant and the
subsequent conversion of Preferred Shares issuable upon exercise of
each such Warrant into Common Shares.
2.4 Closing
Date . The closings for the purchase and sale of the Notes
shall take place at the offices of Michael Best & Friedrich
LLP, One South Pinckney Street, Suite 700, Madison, Wisconsin,
at 10:00 A.M. (Madison, Wisconsin, local time) on May 1,
2003 with respect to the purchase and sale of the Initial Notes and
on the date and at the time designated by the Company in the
Borrowing Request, or on such other dates at such other times or
place as the parties hereto may agree (the date on which the
purchase and sale of the Initial Note occurs is referred to as the
“ Initial Closing Date ” and also referred to,
along with each subsequent date on which the Secondary Notes are
purchased and sold, as a “ Closing Date
”).
-12-
The obligation of
the Investors to enter into the Agreement and to make the Loans and
perform their obligations contemplated hereby is subject to the
accuracy of all representations and warranties by the Company
contained herein, to the performance by the Company of all the
terms and conditions on either of their parts to be performed
hereunder and to the satisfaction of the following conditions
precedent, any of which may be waived by the Required Investors in
their sole discretion by a written waiver specifically referencing
the appropriate section:
3.1 Opinion of
Counsel . The Investors shall have received from counsel for
the Company a favorable opinion addressed to the Investors dated
the Initial Closing Date and incorporating all those matters set
forth in the form attached hereto and incorporated by reference as
Exhibit F .
3.2 Company
Officers . The Company shall have delivered to the Investors a
certificate signed by the Company’s chief executive officer
and president that as of the Initial Closing Date (both before and
after giving effect to the transactions contemplated by this
Agreement):
(a) there
does not exist any state of facts which would constitute an Event
of Default or would, with notice or lapse of time as provided
herein, or both, constitute such an Event of Default;
(b) all
representations and warranties contained in Article IV
are true and correct;
(c) the
Company is in compliance with all of the affirmative and negative
covenants set forth in Article V and
Article VI ; and
(d) all
conditions set forth in Article III to be performed by the
Company have been satisfied.
3.3 Corporate
Resolutions . The Company shall have delivered or made
available to the Investors a certificate signed by the
Company’s chief executive officer and president as of the
Initial Closing Date, attaching a certified copy of the resolutions
adopted by the shareholders and/or Board of Directors of the
Company authorizing and approving (i) this Agreement,
(ii) the incurrence of indebtedness under, the execution,
delivery and issuance of, and the performance of the
Company’s obligations under, the Notes and the Warrants,
(iii) conversion pursuant to Automatic Conversions and
Optional Conversions, and (iv) the other transactions
contemplated hereby.
3.4 Proceedings
and Documents . All proceedings to be taken prior to or on a
Closing Date in connection with the transactions contemplated by
this Agreement shall have been consummated, and all documents,
schedules, exhibits, opinions and certificates related thereto
shall each be satisfactory in form and substance to the Investors
and the Investors shall have received copies of all such documents
which the Investors reasonably have requested in connection with
said transactions.
-13-
3.5
Organization, Good Standing and Authority . The Company
shall be a corporation duly organized, validly existing and in good
standing under the laws of the State of Wisconsin, and shall have
all requisite corporate power and authority to conduct its business
as it is now conducted, to enter into and carry out the provisions
of this Agreement and any other agreement required hereunder and to
perform its obligations hereunder and thereunder. Copies of the
Company’s Articles of Incorporation (including all
amendments) and certificates of status of recent date, both
certified by the Department of Financial Institutions of the State
of Wisconsin, and a copy of the respective Bylaws of the Company
(including all amendments) and a copy of the stock ledger of the
Company, certified by the secretary of the Company, shall have been
delivered to the Investors. The Company shall have complied with
and shall not be in violation of any term or provision of its
Articles of Incorporation (as amended) and Bylaws. The Company
shall be qualified to do business as a foreign corporation in all
jurisdictions where the conduct of its business or the nature of
its activities requires such qualification and where the failure to
qualify would have a Material Adverse Effect.
3.6 Securities
Law Matters; Investment Representations . The Company shall not
be in violation of any provision of federal or state securities
laws applicable to this transaction, and the making of the Loans
and the issuance of the Notes and the Warrants shall be exempt from
registration under the Securities Act and all other applicable
federal and state securities laws.
3.7 No
Litigation . There shall be no action, proceeding or
investigation pending or, to the Knowledge of the Company,
threatened which might result in any Material Adverse
Effect.
3.8
Consents . There shall have been secured from each
Governmental Authority having jurisdiction over the transactions
described herein, and from each Person whose consent to the
transactions described herein is required, all consents, approvals
and permits as shall be necessary or, in the opinion of counsel for
the Investors, appropriate, for the consummation of the
transactions described herein.
3.9 Lien
Search . On the day of funding of the Initial Loan, the Company
shall have delivered to the Investors a lien search, prepared by a
reputable title company acceptable to the Investors, of the records
of the Dane County Register of Deeds, the Department of Financial
Institutions of the State of Wisconsin and the filing offices of
any other jurisdiction in which the Company has substantial assets,
properties, inventories or business operations, disclosing that all
personal property, equipment and fixtures of the Company are free
and clear of all Liens (except Permitted Liens and those Liens
disclosed on Schedule 3.9 hereto).
3.10 No
Material Adverse Effect . There shall not be in existence any
event, including any judicial or administrative proceeding which,
in the opinion of the Investors, would have a Material Adverse
Effect.
3.11
Representations and Warranties . All representations and
warranties of the Company and the Principals in this Agreement
shall be true and correct in all respects as of and
-14-
at the Closing
Date with the same force and effect as though said representations
and warranties had been again made on the Closing Date.
3.12 No
Default . There shall be no Default or Event of Default under
this Agreement or any other Loan Document and no default or event
of default under the Series A Investment Agreement,
Series B Investment Agreement, or Series C Investment
Agreement.
3.13 Use of
Proceeds . The proceeds of the Loans shall be committed for use
in the manner described in Schedule 4.13
hereof.
3.14 Conditions
Precedent for Secondary Loans . The obligations of the
Investors to make each Secondary Loan, the Automatic Conversion and
the Optional Conversion are subject to the satisfaction or waiver
of the following conditions:
(a) There
shall not be in existence any event, including any judicial or
administrative proceeding, which would have a Material Adverse
Effect.
(b) All
representations and warranties in this Agreement shall be true and
correct in all respects as of and at the date of funding of such
Secondary Loan or effectiveness of Automatic Conversion or Optional
Conversion with the same force and effect as though said
representations and warranties had been again made on such Closing
Date or the date of such Automatic Conversion or Optional
Conversion, as the case may be.
(c) There
shall be no Default or Event of Default under this Agreement or any
other Loan Document and no Default or Event of Default will occur
as the result of the making or incurring of the Secondary Loan, the
Automatic Conversion and the Optional Conversion, as the case may
be.
(d) The
proceeds of the Loans shall be committed for use in the manner
specified in the borrowing notice under Section 2.1(b)
hereof, which shall be consistent with Schedule 4.13
.
(e) The
Company shall have delivered to the Investors a certificate signed
by the Company’s chief executive officer and president that
as of the date of such Secondary Loan, Automatic Conversion or
Optional Conversion, as applicable (both before and after giving
effect to the transactions contemplated by thereby), that items (a)
— (d) above are true and correct.
3.15 SBIC
Compliance Agreement . The Company shall have executed and
delivered to Open Prairie Ventures a letter agreement, in form
satisfactory to Open Prairie Ventures, stating that the Company is
in compliance with certain provisions of the SBIC Act, as defined
therein.
-15-
REPRESENTATIONS AND
WARRANTIES
In order to induce
the Investors to execute and deliver this Agreement, the Company
and the Principals (only with respect to Sections 4.2 ,
4.5 , 4.19 and 4.23 ), severally and not
jointly, represent, warrant and covenant, as of the date hereof and
as of such Closing Date, that each of the representations and
warranties contained herein is and shall be true, complete and
correct and acknowledges that such representation and warranty is
independently material to, and relied upon by, the
Investors:
4.1 Existence
and Rights . The Company is a corporation duly organized and
existing under the laws of the State of Wisconsin, without limit as
to the duration of its existence. The Company has all corporate
powers, authority and rights to own its properties, and, to the
best of the Company’s Knowledge, the licenses, franchises and
rights to carry on its business; and is now, and will from time to
time hereafter promptly become and remain, duly qualified and in
good standing in each State or other jurisdiction in which the
character of the properties owned by it therein or the conduct of
its present or proposed business makes such qualification
necessary. Except to the extent of any actions that would be
necessary to authorize the Qualified Series D Financing and to
authorize and issue the Underlying Shares, the Company has all
corporate power and authority to enter into and perform this
Agreement and the transactions contemplated hereby. The Company has
all corporate power and authority to issue the Notes and Warrants
issued pursuant hereto. The Company has the power to reserve and
issue the Underlying Shares, including the Preferred Shares to be
issued upon conversion of the Notes and exercise of the
Warrants.
4.2 Agreement
Authorized . Neither the execution and delivery by the Company
or the Principals of this Agreement, nor the performance by the
Company or the Principals of their obligations hereunder, is in
contravention of, or in conflict with, any law or regulation or any
term or provision of the Company’s Articles of Incorporation
or Bylaws, each as amended, and this Agreement has been duly
authorized and does not require the consent or approval of any
Governmental Authority. All corporate action and all necessary
approvals and consents for the due execution and delivery of this
Agreement, including the authorization and issuance of the Notes
and the Warrants, and the performance of all other transactions
contemplated hereby (except for the actions necessary to authorize
the Qualified Series D Financing and to authorize and issue
the Underlying Shares), have been duly and validly obtained or
taken. No right of the Company or any other Person is illegally
impaired or infringed upon by its execution and/or performance of
this Agreement. This Agreement has been duly executed and delivered
and constitutes the legal, valid and binding obligation of the
Company and the Principals, enforceable against the Company and the
Principals in accordance with its terms, subject only to
bankruptcy, insolvency and other laws which limit or qualify the
rights of creditors generally, and to the availability of specific
performance, injunctive relief or other equitable
remedies.
-16-
(a) The
entire authorized, issued and outstanding capital stock (“
Capital Stock ”) of the Company is as set forth on
Schedule 4.3(a) . The issued and outstanding Capital
Stock is owned by the Persons identified in
Schedule 4.3(a) in the amounts shown therein. All
rights to acquire stock in the Company presently existing,
including but not limited to, the conversion of promissory notes or
other indebtedness or receipt of stock in exchange for royalty,
compensation or other payments are set forth on
Schedule 4.3(a) . All of the outstanding
Company’s capital stock is duly and validly issued, fully
paid and nonassessable (subject to Section 180.0622 of the
Wisconsin Statutes) and in compliance with all applicable state and
federal securities laws concerning the issuance of securities.
Except to the extent of any actions which would be necessary to
authorize the Qualified Series D Financing and to create,
authorize and issue the Underlying Shares, the Company has all
power and authority to (i) issue the Notes, Warrants and
Series C Preferred Shares, (ii) effect Automatic
Conversions and Optional Conversions, (iii) convert the Notes into
Series D Preferred Shares (if an Automatic Conversion) or
Series C Preferred Shares (if an Optional Conversion),
(iv) convert the Warrants into Series D Preferred Shares
or Series C Preferred Shares, as applicable, and
(v) reserve for future issuance, the Underlying Shares
issuable upon conversion of the Notes.
(b) Except
as described in Schedule 4.3(b) , the Company does not
have any outstanding subscriptions, options, warrants or other
rights, restrictions or agreements pertaining to the issuance,
purchase, transfer, or registration of any shares of the
Company’s capital stock, or any securities convertible into
or exchangeable for any shares of the Company’s capital
stock, or any understandings or commitments of any kind except as
contemplated by this Agreement.
4.4
Subsidiaries, Other Investments . The Company does not have
any Subsidiaries or other investments in any other
Person.
4.5
Litigation . There is no litigation or other proceeding
pending or, to the Knowledge of the Company or the Principals,
threatened against or affecting the Company or any of its material
property, and the Company is not in default with respect to any
order, writ, judgment, decree or demand of any court or other
Governmental Authority.
4.6 Financial
Statements . The Financial Statements of the Company delivered
to the Investors and attached hereto as Schedule 4.6
were prepared in accordance with GAAP and fairly present the
financial condition of the Company as of the dates indicated
therein, subject, in the case of the Financial Statements dated as
of December 31, 2002, to normal recurring year-end adjustments
(the effect of which will not, individually or in the aggregate,
have a material adverse effect on the financial condition of the
Company), adjustments to reflect liabilities disclosed on
Schedule 4.9 , and the absence of notes (that if
presented, would not differ materially from those included in the
2001 Financial Statements). Since December 31, 2002, there has
not been:
(a) any
Material Adverse Effect;
(b) any
material damage, destruction or loss (whether or not covered by
insurance) adversely affecting the properties, business or earnings
prospects of the Company; or
-17-
(c) except
for the transactions contemplated by this Agreement, any
transaction outside the ordinary course of the Company’s
business.
4.7 Title to
Properties . The Company owns and has good marketable title to
all of its material Property reflected in the Company’s
Financial Statements contained in Schedule 4.6 . The
Property is not subject to any Liens, except for Permitted
Liens.
4.8
Intellectual Property . Schedule 4.8 lists all
of the following:
(a) patents
and patent applications;
(b) trade
secrets, trademarks, trade names and applications therefor and
service marks; and
(c) licenses
and franchises
currently used
or employed or proposed to be used or employed by the Company (the
“ Intellectual Property ”). The Company owns (or
has valid and enforceable rights to use) all of the Intellectual
Property. The Intellectual Property is all of the intellectual
property that is used in or necessary for the conduct of the
Company’s business as presently conducted and as proposed to
be conducted. Except as otherwise described on
Schedule 4.8 , the Company is the sole owner of all
right, title and interest in the Intellectual Property which it
purports to own and, with respect to Intellectual Property licensed
by the Company, the Company has valid, binding and enforceable
rights to use such Intellectual Property. Schedule 4.8
includes copies of all legal opinions rendered to the Company
pertaining to the patentability of the Intellectual Property and a
summary of all material comments, inquiries or objections from any
filing agency which have been received by the Company.
Schedule 4.8 lists for each item of Intellectual
Property which the Company has, or intends to file a patent
application, the location of each foreign, federal or state agency
or office where the Company has or intends to file such an
application and, if applicable, the registration number and the
date of registration. There are no interference, opposition or
cancellation proceedings pending or, to the Knowledge of the
Company, threatened against the Company or the Intellectual
Property. To the best Knowledge of the Company, the use of the
Intellectual Property and of any trade secrets, secret processes,
inventions, processes or formulas used or employed by the Company
does not infringe upon the rights of any Person. In the event that
it is determined that access to other intellectual property not
already owned by or licensed to the Company is needed for the
Company’s business, the Company will make reasonable good
faith efforts to acquire such intellectual property. No claim, suit
or action is pending or, to the Company’s Knowledge,
threatened alleging that the Company is infringing upon the
intellectual property rights of others. Except by virtue of the
ownership of Company’s Capital Stock, no shareholder,
director, officer or employee of the Company owns, or claims to
own, directly or indirectly, in whole or in part, any Intellectual
Property.
4.9 No
Undisclosed Liabilities . Except as provided in
Schedule 4.10 for contracts entered into after
December 31, 2002 and Schedule 4.9 , the Company
does not have any
-18-
Liabilities
except those reflected or reserved against on the Company’s
Financial Statements attached hereto in Schedule 4.6
.
4.10
Contracts . The Company does not have any existing
contracts, purchase orders, service agreements, commission
arrangements, loan agreements, leases or other contractual
obligations whatsoever which (i) extend beyond one year from
the date hereof, (ii) involve total payments or expenditures
to any single Person of more than Twenty-Five Thousand Dollars
($25,000) on any single contract, except for those terminable by
the Company without cost or penalty upon thirty (30) days
notice, or except as are listed on Schedule 4.10 hereto
or Schedule 4.10 to the Series C Investment Agreement, or
(iii) are with Affiliates of the Company, except as listed on
Schedule 4.10 hereto or Schedule 4.10 to the
Series C Investment Agreement.
Except as
described in Schedule 4.10 hereto or Schedule 4.10
to the Series C Investment Agreement, the Company does not
have, nor is it a party to, any:
(a) employment
or other contracts with employees, consultants or similar
individuals or entities;
(b) pension,
profit or similar employee benefit plans, including but not limited
to, employee pension benefits plans and employee welfare benefit
plans as defined in sections 3(2) and 3(1) of ERISA;
(c) outstanding
loans or borrowing contracts, indentures, mortgages or leases under
which the Company is obligated; and
(d) contract
or agreement, including a joint venture or joint development
agreement with another party that relates to the Company’s
research or product development activities.
4.11 Compliance
with Other Instruments, Laws, Etc. The Company is not in
violation of its Articles of Incorporation or Bylaws, each as
amended; and is not in violation of any applicable law, statute or
regulation of any Governmental Authority relating to the conduct of
its business and maintenance, ownership or operation of its
properties, or in violation of or default with respect to any
order, license, regulation or demand of any Governmental Authority,
or in violation of or default under any indenture, mortgage, lease,
agreement or other instrument under which the Company is obligated.
Neither the execution nor the delivery of this Agreement, nor the
consummation of the transactions contemplated hereby, nor the
fulfillment of the terms hereof, will conflict with, or result in a
breach of the terms, conditions or provisions of, or constitute a
default under any agreement, instrument or Lien under which the
Company is bound or obligated.
4.12 Securities
Laws . The issuance, sale, and delivery of the Notes and the
Warrants and the issuance, sale, and delivery of the Underlying
Shares upon conversion of the Notes and exercise of the Warrants
will be exempt from the requirement of registration under the
Securities Act and state “Blue Sky” laws, and such
Securities Act and “Blue Sky” laws will not be
violated
-19-
by the Company
by the execution of this Agreement or the consummation of the
transactions contemplated hereby. All issuances, sales, and
deliveries of the Capital Stock by the Company prior to such
Closing Date were exempt from the requirements of registration
under the Securities Act and state “Blue Sky” laws and
not in violation of such laws.
4.13 Use of
Proceeds . The funds to be loaned by the Investors to the
Company pursuant to this Agreement will be used for the purposes
set forth in Schedule 4.13 .
4.14
Brokers . The Company is not liable for any finders’
fees, brokerage fees or similar fees or expenses in connection with
entering into the transactions contemplated by this
Agreement.
4.15 Taxes
. The Company has timely filed or caused to be timely filed all tax
returns which are required to be filed by it and has paid and
discharged all lawful taxes, assessments and governmental charges
or levies imposed upon it or upon its income or profits, or upon
any of its properties, real, personal or mixed; and no tax Liens
have been filed and no claims are being asserted with respect to
any such taxes, fees or other charges.
4.16
Insurance . The respective assets of the Company are
adequately insured against all such liabilities, hazards and risks,
and in at least such amounts as are usually carried by Persons
engaged in the same line of business (in the case of property
casualty insurance, at least replacement cost). All premiums on
policies due to date have been paid, and no notice has been
received, nor has the Company any reason to believe, that any such
insurance will be canceled or not renewed.
4.17 Federal
Reserve Regulations . The Company will not, directly or
indirectly use funds loaned by the Investors hereunder for the
purpose of purchasing or carrying any “margin stock”
within the meaning of Regulations G, U, T or X of the Board of
Governors of the Federal Reserve System (12 C.F.R. Parts 221 and
224, as amended), or otherwise take or permit any action which
would involve a violation of any regulation of the Board of
Governors of the Federal Reserve System.
4.18 Investment
Company Act: Public Utility Holding Company Act . The Company
is not: (a) an “investment company” or a company
“controlled by an investment company” within the
meaning of the Investment Company Act of 1940, as amended; or
(b) a “holding company” or a
“subsidiary” of a “holding company” or an
“affiliate” of a “holding company” or a
“subsidiary” of a “holding company” within
the meaning of the Public Utility Holding Company Act of 1935, as
amended.
4.19
Nondisclosure, Noncompetition and Inventions Agreements;
Employees . Each of the Company’s employees has entered
into a nondisclosure, noncompetition and inventions agreement in
substantially the form attached to Schedule 4.19 of the
Series C Investment Agreement and such agreements are in full
force and effect, and have not been amended, restated, supplemented
or otherwise modified, nor has any Principal or other employee of
the Company breached its terms and conditions. Except as to David
Murray, the Company has no
-20-
Knowledge of
any employee who has announced their intention to terminate their
employment with the Company or who the Company has reason to
believe will terminate their employment with the
Company.
4.20 Small
Business Matters . The Company, together with its
“affiliates” (as that term is defined in Title 13, Code
of Federal Regulations, § 121.103), is a “small business
concern” within the meaning of the Small Business Investment
Act of 1958 and the regulations thereunder, including Title 13,
Code of Federal Regulations, § 121.103. The information
regarding the Company and its affiliates set forth in the Small
Business Administration Form 480, Form 652 and Parts A
and B of Form 1031 delivered at the Closing is accurate and
complete. Copies of such forms shall have been completed and
executed by the Company and delivered at the Closing together with
a written statement of the Company regarding its planned use of the
proceeds from the sale of the Notes and the Warrants. The Company
does not presently engage in, and it shall not hereafter engage in,
any activities, nor shall the Company use directly or indirectly
the proceeds from the sale of the Notes and the Warrants hereunder
for any purpose, for which a Small Business Investment Company is
prohibited from providing funds by the Small Business Investment
Act of 1958 and the regulations thereunder (including Title 13,
Code of Federal Regulations, § 107.720). The Company
acknowledges that Open Prairie Ventures is a federal licensee under
the Small Business Investment Act of 1958, as amended.
4.21 Amendments
to the Articles of Incorporation and Bylaws . Since
August 28, 2002, the Company has not amended or changed in any
way its Articles of Incorporation or Bylaws, nor has it filed any
amendments thereto with the Wisconsin Department of Financial
Institutions or any other Governmental Authority.
4.22 No
Default . There exists no Default or Event of Default under
this Agreement or any other Loan Document and no default or event
of default exists under the Series A Investment Agreement,
Series B Investment Agreement, or Series C Investment
Agreement.
4.23 Survival
of Representations and Warranties . All representations and
warranties contained herein or made by or on behalf of the Company
and/or the Principals in writing in connection with the
transactions contemplated herein, for purposes of
Article VII of this Agreement and Investors’
rights and remedies thereunder (whether for establishing damages
caused by such Event of Default or exercising the right of optional
redemption), shall survive the consummation of the transactions
contemplated hereby and continue in effect at all times while any
Investor holds a Note, Warrant or any Capital Stock. All statements
contained in any certificate or other instrument or schedule
attached hereto or delivered by or on behalf of the Company and/or
the Principals pursuant hereto, or in connection with the
transactions contemplated herein, shall constitute representations
and warranties by the Company and/or the Principals hereunder. The
foregoing representations and warranties do not contain any untrue
statement of material fact or omit to state any material fact
necessary to make the statements therein not misleading. There is
no fact known to the Company or the Principals which has not been
disclosed to the Investors which could reasonably be expected to
have a Material Adverse Effect.
-21-
In order to induce
the Investors to execute this Agreement, the Company covenants and
agrees that from the Initial Closing Date, and for the benefit of
each Investor,
(i) until
the Loans are repaid in full or the Investors dispose of all of
their shares of Series D Preferred Shares acquired upon
conversion of the Notes or exercise of the Warrants, or
(ii) if
the Loans are converted to Series C Preferred Shares pursuant
to Section 2.2(b) , until the earlier to occur of
(w) such Investor owning less than twenty percent (20%) of the
number of Series C Preferred Shares owned by such Investor as
of the Optional Conversion Date, including shares issuable upon the
exercise of any options, warrants or other convertible securities
owned by such Investor as of such date, adjusted for any stock
dividend, stock splits and the like as provided for in the
Shareholders Agreement, (x) the consummation of a Qualified
Public Offering by the Company, (y) the sale of all or
substantially all of the Company’s Capital Stock through
merger or otherwise (including all Preferred Shares and Common
Shares held by the Investors), or (z) the Company sells all or
substantially all of the Company’s assets for cash and/or
securities registered under the Securities Act and promptly
distributes such proceeds to its shareholders,
it will comply,
unless the Required Investors shall otherwise consent in writing,
with the following provisions:
5.1 Taxes .
The Company shall promptly pay and discharge all lawful taxes,
assessments and governmental charges or levies imposed upon it or
upon its income or profits, or upon any of its properties, real,
personal or mixed; provided , however , that the
Company shall not be required to pay or cause to be paid any such
tax, assessment, charge or levy if the same shall not at the time
be due and payable or if the validity thereof shall concurrently be
contested in good faith by appropriate proceedings and if the
Company shall have established adequate reserves on its books with
respect to such tax, assessment, charge or levy; provided
further , that the Company will pay all such taxes,
assessments, charges or levies forthwith whenever, as the result of
proceedings to foreclose any Lien which attached as security
therefor, foreclosure on such Lien appears imminent, or (at the
election of the Company) will obtain a surety bond or take such
other steps as will prevent such foreclosure.
5.2 Maintain
Corporate Existence and Rights . The Company shall maintain and
preserve its corporate existence and such rights, franchises,
qualifications and Intellectual Property as are adequate to the
conduct of its business and ownership of its properties, if the
failure to maintain and preserve such rights, franchises,
qualifications and Intellectual Property would have a Material
Adverse Effect.
-22-
5.3
Insurance . The Company shall maintain such insurance
against liabilities, hazards and risk, and in at least such amounts
(at least replacement cost), as are usually carried by Persons
engaged in the same or similar businesses. All such insurance shall
be effected under valid and enforceable policies issued by insurers
of recognized responsibility, except that the Company may effect
worker’s compensation or similar insurance in respect of
operations in any state or other jurisdictions through an insurance
fund operated by such state or other jurisdiction.
5.4 Financial
Reports . The following financial reports shall be provided to
the Investors or Minimum Investors, as the case may be, as set
forth below:
(a) Within
twenty (20) days after the end of each month, to each Minimum
Investor, unaudited consolidated and consolidating financial
statements (including balance sheet, statement of cash flow, income
statement, and statement of shareholders’ equity) of the
Company for such fiscal month and for the then current fiscal year
to date, all in reasonable detail as requested by the Minimum
Investors prepared in accordance with GAAP.
|